top of page

Advanz Pharma: Revolutionizing Specialty, Hospital, and Rare Disease Medicines

Advanz Pharma has emerged as a global frontrunner in the pharmaceutical industry, with a specific focus on specialty, hospital, and rare disease medicines. Their core mission is to enhance patient’s lives by providing innovative and effective medical solutions.

Company Overview

Headquartered in London, UK, Advanz Pharma has a significant global footprint with sales in over 90 countries worldwide. They have direct commercial operations in more than 20 countries, including key markets such as Europe, the US, Canada, and Australia.

Global Presence and Distribution Network

Their global presence is further bolstered by an established Centre of Excellence in Mumbai, India, and a robust distribution and commercialization partner network.

Diverse Product Portfolio

Advanz Pharma boasts a comprehensive product portfolio and pipeline, including innovative medicines, specialty generics & biosimilars, and originator brands. These products cover an extensive range of therapeutic areas:

  • Hepatology

  • Gastroenterology

  • Anti-infectives

  • Critical Care

  • Endocrinology

  • Oncology

  • CNS

  • Rare Disease Medicines

Strategic Partnerships

Advanz Pharma has set a high ambition to become the partner of choice for the commercialization of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. This ambition aligns perfectly with their strategy to collaborate with biopharma and development companies to bring medicines to patients.

Team and Values

Their success is largely attributed to their dedicated and highly qualified team of employees who uphold the company values of entrepreneurship, speed, and integrity.

print("Advanz Pharma is leading the way in providing innovative and specialty medical solutions to patients globally.")

"Our ambition is to be a partner of choice for the commercialization of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia." - Advanz Pharma

Conclusion

With their commitment to improving patient lives, strategic partnerships, and a diverse product portfolio, Advanz Pharma is indeed revolutionizing the global pharmaceutical industry.

  1. Global Presence: Commercial sales in more than 90 countries worldwide.

  2. Diverse Product Portfolio: Innovative medicines, specialty generics & biosimilars, and originator brands.

  3. Strategic Partnerships: Collaborations with biopharma and development companies.

By upholding their company values of entrepreneurship, speed, and integrity, they continue to be at the forefront of providing specialty, hospital, and rare disease medicines.

1 view

Recent Posts

See All

Biogen's Acquisition of Reata Pharmaceuticals

Introduction In a significant development for the medical community, Biogen Inc. (Nasdaq: BIIB) has announced its definitive agreement to acquire Reata Pharmaceuticals, Inc. (Nasdaq: RETA). This strat

Comments


bottom of page